Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Blood Research & Hematologic Diseases
Richard T Silver Author
Subjects of specialization
Affiliation
Principle of program, Retinoid, Senescence, ROS, Drug-Resistance
The Richard T. Silver, MD Myeloproliferative Neoplasm Center, Division of Hematology
Biography
There are no conflicts of interest and no financial interest. Both authors conceived and wrote the paper. This article was supported in part by the Cancer Research and Treatment Fund, Inc. Ms. Maria Wright provided excellent secretarial support
Publications
Editorial Open Access
Optimal Therapy for Polycythemia Vera and Essential Thrombocythemia: A Different Perspective
Author(s): Richard T Silver and Hans Carl Hasselbalch
Recent publications have de-emphasized the importance of recombinant interferon alpha (rIFNα) for the treatment of polycythemia vera (PV) or essential thrombocythemia (ET), favoring the use of phlebotomy and/or hydroxyurea. Here we express our reasons for the use of rIFNα early in the course of PV or ET in the absence of a phase 3 trial.
... view more»Social Media
Google Scholars / Researchers Sites
